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Prostaglandins Mediate Arteriolar Dilation to
Increased Blood Flow Velocity in Skeletal
Muscle Microcirculation
Akos Koller and Gabor Kaley
In cremaster muscle of pentobarbital-anesthetized rats, temporary occlusion of an arteriole
increased red blood cell velocity (mean increase, 8.2±1.0 mm/sec from a control velocity of
7.9+0.7 mm/sec) in proximal parallel arteriolar branches (mean control diameter, 19.4+±0.6
,um). Increases in flow velocity were consistently followed by proportional delayed (6-15
seconds) increases in arteriolar diameter (5.8+±0.7 g&m). Administration of NG-monomethyl-L-
arginine (200 ,M), an inhibitor of the synthesis of endothelium-derived relaxing factor that
blocked the arteriolar responses to acetylcholine (1 ,uM) but not to arachidonic acid (10 ,uM),
did not affect the dilation (mean increase, 8.9±1.1 ,m) due to increases in red blood cell
velocity (13.4±1.5 mm/sec). However, the cyclooxygenase inhibitor indomethacin (or
meclofenamate), which completely blocked the dilator response to arachidonic acid but did not
change the response to acetylcholine, inhibited the arteriolar dilation (mean increase, 0.3+±0.2
,um) due to increases in red blood cell velocity (9.3±1.0 mm/sec). Inhibition of prostaglandin
synthesis also reduced the increase in calculated blood flow by 57% during occlusion. These
results suggest that the arterioles are sensitive to increases in blood flow velocity (wall shear
stress), in response to which they release prostaglandins, eliciting vasodilation. The existence
of this phenomenon in the skeletal muscle microcirculation suggests a new regulatory
mechanism that, by modulation of vascular resistance in the microvascular network, has the
role of normalizing wall shear stress and providing for substantial increases in tissue blood
flow. (Circulation Research 1990;67:529-534)
R ecently, we have reported that in skeletal
muscle microcirculation, an increase in blood
flow velocity elicits dilation of arterioles1 and
that this phenomenon is dependent on vascular
endothelium.2 The nature of the endothelial mediation,
however, has not yet been clarified in the microcircu-
lation in vivo. In large vessels, both endothelium-
derived relaxing factor (EDRF)3 and a nonprostaglan-
din metabolite of arachidonic acid4 have been
suggested as mediators of a similar "flow-dependent"
dilator response. Previously, it was also reported that
exposure of cultured endothelial cells5,6 to increases in
shear stress results in release of vasoactive prostaglan-
dins. In the present experiments, using parallel
occlusion1- a method to elicit an increase in arteriolar
blood flow velocity- and inhibitors of prostaglandin
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synthesis (indomethacin or meclofenamate), as well as
an inhibitor of EDRF production (NG-monomethyl-L-
arginine [NMA]7-9), we demonstrate that in skeletal
muscle microcirculation in vivo, the flow velocity (shear
stress)-sensitive vasoregulatory mechanism is medi-
ated by prostaglandins.
Methods
Male Wistar rats 5-6 weeks of age were anesthe-
tized with a subcutaneous injection of pentobarbital
sodium (35 mg/kg). A constant level of anesthesia
was maintained throughout the experiment by sub-
cutaneous injection of supplemental doses (20% of
original dose) of the anesthetic agent every 30-45
minutes. The trachea was cannulated to facilitate
respiration. Arterial blood pressure was monitored
with a Statham P23 D6 transducer (Gould Inc.,
Oxnard, Calif.) connected to a cannula inserted in
the left common carotid artery and recorded on a
Sensormedics Dynograph recorder (model R511A,
Anaheim, Calif.). The left cremaster muscle was
surgically exteriorized with effort to maintain an
intact blood and nerve supply. Throughout the sur-
gical procedure and during the experiment, the mus-
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cle was superfused with Krebs' solution at a rate of 2
ml/min. The pH of this solution was 7.4; it contained
millimolar concentrations of NaCI 154, KCl 5.6,
CaCl2 2.2, and MgSO4 1.2 and was bubbled with 5%
C02-95% N2. The temperature of the animal, the
superfusion solution, and the supporting Plexiglas
platform for the muscle were thermostatically con-
trolled at 370, 33.50, and 33.5° C, respectively. These
conditions provided for a stable preparation through-
out the course of the experiments.
After surgery, 30-40 minutes was allowed to reach
a steady state of baseline arteriolar tone. The image
of the microvessels was recorded on a videorecorder
with a television microscope (Olympus, Lake Suc-
cess, N.Y.) using a x20 objective with 0.4 N.A. and
transillumination with a tungsten lamp. The resting
(control) internal diameter of arterioles and the peak
changes in diameter in response to experimental
intervention and vasoactive agents were measured
with an image-shearing monitor,10 and red blood cell
(RBC) velocity (an indicator of blood flow velocity)
was measured with a self-tracking correlator (models
907 and 102B, respectively, IPM, San Diego); the
latter was calibrated with a disk coated with dried
RBCs rotating in the focal plane.'1
Increase in wall shear stress was elicited by an
increase in blood flow velocityl"2 (wall shear stress=
,udV/dr, where ,g is viscosity, V is velocity, and r is
radius). This was obtained by occluding (up to 2.5
minutes) an arteriole (40-60 ,um in diameter). Dur-
ing this intervention, we followed the events occur-
ring in one of the several parallel arterioles (diame-
ter, 15.7-23.5 gm) branching off proximally (500-
2,000 gm) from the occlusion. To avoid confusion
with the earlier frequently investigated method of
serial occlusion, we named this intervention "parallel
occlusion."1"2 Because blood flow supply to the re-
gion studied is constant, it follows, according to the
law of conservation of mass, that occlusion of an
arteriole will result in an increase in blood flow (and
blood flow velocity) in the several proximal parallel
arterioles. Arteriolar blood flow (Q) was calculated
by Q=Vmr2wr, where Vm (mean velocity) is obtained
by Vrb!f, where f=1.6>15 ,um<1.3. Arteriolar re-
sponses to parallel occlusion were recorded during
control conditions and after 30 minutes of superfu-
sion, followed by continuous administration of indo-
methacin (10 ,ug/ml) or meclofenamate (10 ,ug/ml),
or NMA (200 ,uM) (number of animals, 8, 3, and 7,
respectively; 1-3 occlusions were performed in each
experimental condition). The microoccluder was fab-
ricated from stainless steel wire and had a tip of
approximately 60 gm. The micromanipulator (Nar-
ishige U.S.A., Greenvale, N.Y.), used to precisely
position the microoccluder, was secured on the ani-
mal stage, which allows for free movement of the
preparation without interfering with the occlusion.
Basal diameter and peak changes in diameter due
to topical acetylcholine (1 ,M) and arachidonic acid
(10 ,uM) of the same segments of arterioles used for
flow velocity studies were determined before and
during indomethacin, meclofenamate, or NMA
administration. Between each application of an agent,
about 5 minutes was allowed for the vessel diameter to
return to control. All vasoactive substances (80 ul)
were administered topically on the arteriole under
investigation with a micropipette without interrupting
the flow of the superfusion fluid. Appropriate dilution
of substances was made with Krebs' solution before
administration. Acetylcholine chloride and arachi-
donic acid were obtained from Sigma Chemical Co.,
St. Louis. Indomethacin was provided by Merck Sharp
& Dohme, Rahway, N.J., and meclofenamate by
Parke-Davis Co., Morris Plains, N.J. NMA was
obtained from Calbiochem Co., La Jolla, Calif., as the
sulfonate salt.
Data reported are mean+SEM, with n indicating
the number of experimental interventions. Statistical
analyses were performed using Student's t test, and
regression analysis, as appropriate. A p value less
than 0.05 was considered significant.
Results
The mean arterial blood pressure of individual rats
did not change over the entire experimental protocol
and was within a range of 95-120 mm Hg.
An original recording in Figure 1A depicts the
changes in RBC velocity and arteriolar diameter
before, during, and after parallel arteriolar occlusion.
At the onset of occlusion, RBC velocity started to
increase in the arteriole under study, which was then
followed (in this case after an approximate 8-second
delay) by an increase in arteriolar diameter. First
RBC velocity then diameter reached a peak value.
On release of the parallel occlusion, RBC velocity
decreased, followed by a slower decline in diameter.
The increase in RBC velocity always preceded (by
6-15 seconds) the increase in diameter. It is of note
that when RBC velocity did not increase during
parallel occlusion, there was also no vasodilation.
Next, we investigated the question of whether
dilation of the arteriole due to increased blood flow
velocity depends on the production of prostaglandins
or EDRF in skeletal muscle microcirculation. Origi-
nal recordings in Figure 1 demonstrate that superfu-
sion of the preparation with indomethacin (panel C)
or meclofenamate (panel D) completely eliminates
arteriolar dilation despite the sharp increases in RBC
velocity. In the later phase of the parallel occlusion,
a return of diameter to control or a slight dilation
(1-2 gm) was observed. Figure 1 also illustrates that
NMA treatment (panel B) did not affect arteriolar
dilation due to increased RBC velocity.
Because of the variable structure of the arteriolar
subnetworks proximal and distal from the occluder,
each arteriole under study exhibited different increases
in RBC velocity during occlusion. In Figure 2, the peak
increases in RBC velocity during parallel occlusion in
control conditions (n= 17), and after indomethacin
(n=24), meclofenamate (n=6), or NMA (n= 15) treat-
ment was plotted against the peak changes in arteri-
olar diameter. Regression analysis of control data
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FIGURE 1. Original record of changes in red blood cell (RBC) velocity and diameter of rat cremasteric arterioles during parallel
arteriolar branch occlusion (see details in "Methods"). The arteriolar dilation seen in control conditions (panel A) was inhibited
by indomethacin (panel C) and meclofenamate (panel D), but not by NG-monomethyl-L-arginine (NMA) (panel B). 0, parallel
arteriolar branch occlusion; R, release. The dotted line indicates the onset ofdiameter increase; note that by this time RBC velocity
has already increased.
indicates a positive linear correlation (r=0.76,
p<0.05) between peak increases in RBC velocity
(mean increase, 8.2±+1.0 mm/sec from a mean of
7.9±+0.7 mm/sec, p<0.05) and arteriolar diameter
(mean increase, 5.8-+ 0.7 gm from a mean of 19.4±+
0.6 ,um, p<0.05). However, arteriolar dilation due to
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similar increases in RBC velocity (mean increase,
9.3±+ 1.0 mm/sec from a mean of 9.1±+0.7 mm/sec,
p<0.05) was nearly eliminated by indomethacin or
meclofenamate, and no correlation was found
between velocity and diameter (mean increase in
diameter, 0.3+0.2 gm). In contrast, NMA treatment
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vINDO FIGURE 2. Regression analysis ofpaired
. NMA data indicates that thepeak changes in red
cl MECLO blood cell velocity and arteriolar diameter
duringparallel arteriolarocclusion in control
conditions (filled circle, continuous line),
and NG-monomethyl-L-arginine (NMA)
treatment (open triangles, dotted line) are
linearly correlated (y=[0.51 +0.1]x+1.6,
r=0.76; p<0.05, and y=[0.69+0.1]x-0.4,
r=0.93; p<0.05, respectively). Indometh-
acin (INDO) (filled triangles) or meclo-
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ment inhibited arteriolar dilation after
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TABLE 1. Effect of Indomethacin, Meclofenamate, and NG_Monomethyl-L-Arginine Treatment on Peak changes in
Arteriolar Diameter After Administration of Acetylcholine and Arachidonic Acid
Change in arteriolar diameter (,um)
Control INDO and MECLO treated NMA treated
Acetylcholine (1 ,uM) 5.7+0.3 6.3+0.9 1.3+0.4*
Arachidonic acid (10 ,uM) 6.0+0.7 -0.8+0.4* 7.9±1.1
Values are mean±SEM; n=7-20. INDO, indomethacin; MECLO, meclofenamate; NMA, NG-monomethyl-L-
arginine.
*p<0.05 vs. control.
had no effect on arteriolar dilation (mean increase,
8.9 + 1.1 ,um) after increases in RBC velocity (mean
increase, 13.4+1.5 mm/sec from a mean of 5.9+1.0
mm/sec, p<0.05) (r=0.93, p<0.05). Because both
velocity and diameter increased, calculated arteriolar
blood flow also increased by 260±52% (from a mean
of 1.5+±0.2 nl) during parallel occlusion in control
conditions. After inhibition of prostaglandin synthesis,
however, this increase was only 112±27%, whereas
NMA did not affect the flow increase.
The efficacy of the inhibitors of prostaglandin or
EDRF synthesis (indomethacin, meclofenamate, or
NMA) was tested immediately before studying their
effect, in the same vessel segment, on the blood flow
velocity-induced arteriolar dilation. Inhibition of
prostaglandin or EDRF synthesis by itself caused a
slight but significant decrease in vessel diameter
(from 20.1±0.9 to 17.7±0.9 ,um or from 18.7±0.5 to
15.8±0.8 ,um, respectively). Data summarized in
Table 1 demonstrate that arteriolar dilation due to
arachidonic acid (10 ,uM), but not to acetylcholine (1
,uM), was completely inhibited by indomethacin or
meclofenamate treatment. Data obtained with the
two cyclooxygenase blockers were pooled. In con-
trast, dilation due to acetylcholine, but not to arachi-
donic acid, was significantly blocked by NMA.
Discussion
In the present study, a significant correlation was
found between peak increases in blood flow velocity
and arteriolar diameter, providing further evidence
that changes in wall shear stress due to increases in
blood flow velocity are coupled to changes in vascular
resistance. We also demonstrated that this coupling
is mediated by prostaglandins in the arterioles of
skeletal muscle microcirculation.
Investigation of endothelial cells of large vessel
origin in tissue culture,56 in large conduit arteries,3'12
in arcade vessels of mesentery,'3 and in skeletal
muscle microcirculation1'2 suggested that the reason
for the "flow-dependent" dilation is the increase in
shear stress at the surface of endothelial cells, which
stimulates the release of mediators, causing relax-
ation of vascular smooth muscle. Although results of
most in vitro studies indicate that the presence of
endothelium is necessary for "flow-induced relax-
ation" to occur,'2 this vascular reaction was observed
in isolated resistance arteries even after removal of
endothelium.14
In a variety of studies, several endothelial mediators
of this phenomenon were identified. In isolated,
Krebs-Ringer-perfused canine femoral and left cir-
cumflex coronary arteries, Rubanyi et a13 found that
an increase in flow released a nonprostaglandin vaso-
relaxant mediator similar in nature to EDRF. A
similar mediator was suggested to have a role in the
control of resistance in the isolated, buffer-perfused
rabbit ear preparation.15 In a blood-perfused canine
femoral artery shunt, Kaiser et a14 reported that the
flow-dependent dilation is mediated by a nonpros-
taglandin metabolite of arachidonic acid. On the other
hand, studies using cultured endothelial cells demon-
strated the importance of prostaglandin release5,6 or
activation of K' channels16 in response to step
increases in fluid shear stress. Our previous study2
demonstrated the importance of arteriolar endothe-
lium in the mediation of the flow velocity (wall shear
stress) -sensitive arteriolar responses in vivo; however,
the nature of mediation was not clarified.
In the present experiments, as illustrated by Figures
1 and 2, NMA, a blocker of EDRF production,7-9 did
not affect arteriolar dilation after blood flow velocity
increased. On the other hand, both indomethacin and
meclofenamate, specific, structurally dissimilar inhib-
itors of prostaglandin synthesis, completely blocked
arteriolar dilation due to increases in blood flow
velocity. It is believed that the primary source of
vasoactive prostaglandins in the vessel wall is the
endothelial cell layer.1718 In our previous studies19'20
using light/dye treatment to impair the endothelium-
associated vasoactive functions in skeletal muscle
arterioles,21 we found that arteriolar dilation due to
arachidonic acid was absent. These findings support
the idea that the vasodilator prostaglandins E2 and '2
released from arteriolar endothelium are responsible
for flow velocity-induced dilation. Furthermore, it is
likely that arteriolar dilation due to increased flow
velocity during control conditions is neither of myo-
genic"2 origin nor the result of metabolic factors from
skeletal or vascular smooth muscle, because blood
flow greatly increases, and pressure, if anything, also
increases in the arteriole under study during parallel
occlusion. An increase in pressure, if unopposed,
would result in a myogenic constriction of the arteri-
ole, the opposite of the observed response. Thus, our
findings also suggest that the "flow-sensitive" prosta-
glandin-mediated dilator mechanism can counteract
the pressure-sensitive myogenic constriction. In this
context, Hill et a122 recently found that inhibition of
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prostaglandin synthesis potentiates myogenic constric-
tion of arterioles. Interestingly, such potentiation of
the myogenic response was also observed in the course
of our previous study when the "flow sensitivity" of
arterioles was abolished by the impairment of arteri-
olar endothelium.2
It is of note that contrary to our previous experi-
ments in which arteriolar endothelium was impaired
by light/dye treatment,1,2 a return toward control or
even an increase in diameter (1-2 ,um) was observed
in the later phases of parallel occlusion after pros-
taglandin synthesis inhibition. This indicates the pos-
sible involvement of other endothelial mechanisms or
factors, albeit to a much lesser degree than prosta-
glandins, in the dilation of arterioles during the later
phases of parallel occlusion. In our experiments,
because blockers of both prostaglandins and EDRF
by themselves elicited small but significant decreases
in arteriolar diameter (12% and 15%, respectively),
we suspect that these mediators are released contin-
uously and that they affect basal vascular tone.19,20
Based on the above, we conclude that in skeletal
muscle microcirculation, the increase in arteriolar
diameter is induced by vasodilator prostaglandins
produced in arteriolar endothelium due to an increase
in wall shear stress (increase in flow velocity with fixed
diameter), which could be sensed by "rheoreceptors"
on the endothelial cell membrane.16 Once the vasodi-
lation is evoked, it in turn would elicit a decrease in
wall shear stress by way of negative feedback because
this force is inversely related to vessel diameter. The
potency and possible importance of this mechanism is
further underscored by the finding that arterioles
could dilate near maximally to changes in this flow-
related force (a dilation equivalent to that elicited by
topical application of iO-` M adenosine19).
Analysis of our data also revealed the importance
of the shear stress-sensitive mechanism in the regu-
lation of blood flow, as inhibition of prostaglandin
synthesis resulted in a 57% reduction in flow increase
during parallel occlusion. It is interesting to note the
previous findings of Messina et a123 showing that
inhibitors of prostaglandin synthesis significantly
inhibit arteriolar reactive dilation after serial occlu-
sions (up to 60 seconds) in cremaster muscle.
Although in that study the blood flow velocity-
sensitive mechanism was not considered as one of the
mechanisms eliciting reactive dilation, it is quite
conceivable in light of the present work that the
sudden increase in blood flow velocity after release of
arteriolar occlusion initiates the release of prosta-
glandins, which, in concert with other mechanisms,
participates in the development of reactive hyper-
emia. It is also of note that EDRF does not seem to
be involved in this response because, as we have
shown previously, inhibition of EDRF by NMA did
not affect the reactive dilation of single arterioles in
rat skeletal muscle microcirculation.24
Based on present and previous studies,1-6,12-14 it
seems reasonable to assume that a wall shear stress-
sensitive dilator mechanism is present throughout
the microcirculatory network and that, through sec-
ondary changes in diameter, it could provide for a
redistribution of resistance and a change in tissue
blood flow. If the resistance of distal elements of the
network decreases (e.g., during functional or reactive
hyperemia, or neurogenically or humorally induced
vasodilation), it could evoke an increase in upstream
blood flow velocity followed by a secondary dilation
of upstream resistance elements (i.e., arteries).25
Dilation of upstream vessels in turn could provide for
a substantially increased blood flow in case of
increased tissue demand and could at the same time
minimize the pressure drop in the network. Such a
mechanism could also be important in the develop-
ment of collateral blood flow,26 in response to changes
in blood viscosity,27 and could participate as a modu-
lating factor across the entire network should pressure
or resistance change for any reason (e.g., because of
constrictor or dilator agents).
In summary, in rat cremaster muscle, increases in
blood flow velocity resulted in dilation of arterioles,
which was mediated by prostaglandins. The presence
of this phenomenon suggests a new, endothelium-
dependent, blood flow-regulatory mechanism that
has the role of normalizing wall shear stress, and
which, by recruitment of upstream vessels, can pro-
vide the necessary change in the structure of the
microvascular network to provide for a substantial
increase in blood supply to the tissue. The impair-
ment of this mechanism in various pathological con-
ditions affecting endothelium and/or prostaglandin
synthesis (e.g., atherosclerosis, diabetes, and hyper-
tension) could contribute further to the pathogenesis
of these disorders.
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